Emilie Aguado

Head of Upstream, MSAT Vitry at Sanofi

Speaker

Emilie has an engineer diploma in Biotechnology. She first started her career in 2010 in Sanofi Pasteur in Marcy l’Etoile working in Mtech department first on Hepatitis A vaccine then on supplier change evaluation for all vaccines in Marcy l’Etoile. In 2012, she started working on gene therapy in Genethon / Yposkesi, first on qualification of equipment & utilities, then as an industrial development engineer in USP/DSP/Fill & finish. In 2019, she joined Sanofi in Vitry sur seine to work in MSAT on monoclonal antibodies. She worked on several tech transfer / validation / continuous process verification as an USP SME for monoclonal antibodies (Sarclisa, Kevzara, Praluent) and for SARS COV 2 vaccine. She became head of upstream in 2022 and is now managing a team of MSAT USP engineers.